3,3-Diphenylpropylamine

3,3-Diphenylpropylamine
Names
	Preferred IUPAC name 3,3-Diphenylpropan-1-amine
Identifiers
CAS Number	5586-73-2 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL609579 ;
ChemSpider	71998 ;
ECHA InfoCard	100.024.532
PubChem CID	79698;
UNII	C31E561S64 ;
CompTox Dashboard (EPA)	DTXSID30204458 ;
	InChI InChI=1S/C15H17N/c16-12-11-15(13-7-3-1-4-8-13)14-9-5-2-6-10-14/h1-10,15H,11-12,16H2 Key: KISZTEOELCMZPY-UHFFFAOYSA-N ;
	SMILES C1=CC=C(C=C1)C(CCN)C2=CC=CC=C2;
Properties
Chemical formula	C15H17N
Molar mass	211.308 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

3,3-Diphenylpropylamine is a form of diphenylpropylamine.

It is commonly conjugated to another agent giving a "bifunctional" molecule. Such agents are not infrequently used to treat Cardiovascular disease (CVD).

Further embellishment of the molecular structure can lead to an agent that is called Delucemine.

3,3-Diphenylpropylamine derivatives list table
Name	Identifier	Picture
BIIA 0388	CID:9958467 [337359-07-6]
BZP derivative	^[1]
Droprenilamine	[57653-27-7]
Fendiline	[13042-18-7]
Lercanidipine	[100427-26-7]
KD-983	[50597-65-4]
Mepramidil	[23891-60-3]
Milverine	[75437-14-8]
PF 244	Fb: [52017-07-9]
Prenylamine	[390-64-7]
SoRI-20041	now SRI-20041
Tiopropamine	[39516-21-7]

[117-34-0] [5586-73-2] amide:^[2]

References

↑ Tadayuki Suzuki & Toshiharu Megumi, U.S. Patent 3,957,790 (1976 to Tokyo Tanabe Co Ltd).
↑ Urbani, P., Cascio, M. G., Ramunno, A., Bisogno, T., Saturnino, C., Marzo, V. D. (August 2008). "Novel sterically hindered cannabinoid CB1 receptor ligands". Bioorganic & Medicinal Chemistry. 16 (15): 7510–7515. doi:10.1016/j.bmc.2008.06.001. hdl:11563/122572. PMID 18579386.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Tadayuki Suzuki & Toshiharu Megumi, U.S. Patent 3,957,790 (1976 to Tokyo Tanabe Co Ltd).

[2] Urbani, P., Cascio, M. G., Ramunno, A., Bisogno, T., Saturnino, C., Marzo, V. D. (August 2008). "Novel sterically hindered cannabinoid CB1 receptor ligands". Bioorganic & Medicinal Chemistry. 16 (15): 7510–7515. doi:10.1016/j.bmc.2008.06.001. hdl:11563/122572. PMID 18579386.

[1]

[2]